A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

Clinical trial NCT06394804 · RECRUITING

Trial details

NCT number: NCT06394804
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Low-Grade Serous Ovarian Cancer

Start date: 2024-04-29
Primary completion: 2027-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.